Based on the findings of this study, it can be conclusively stated that serum cystatin C serves as a highly sensitive and reliable biomarker for the detection and evaluation of CKD, demonstrating a strong correlation with serum creatinine and a superior inverse relationship with eGFR in patients WITH CKD. This evidence concerns the gene CST3 and chronic kidney disease.